These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 32445619)

  • 1. Single-Cell RNA Sequencing of Tumor-Infiltrating NK Cells Reveals that Inhibition of Transcription Factor HIF-1α Unleashes NK Cell Activity.
    Ni J; Wang X; Stojanovic A; Zhang Q; Wincher M; Bühler L; Arnold A; Correia MP; Winkler M; Koch PS; Sexl V; Höfer T; Cerwenka A
    Immunity; 2020 Jun; 52(6):1075-1087.e8. PubMed ID: 32445619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma.
    Nakazawa T; Morimoto T; Maeoka R; Yamada K; Matsuda R; Nakamura M; Nishimura F; Yamada S; Park YS; Tsujimura T; Nakagawa I
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
    Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
    Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-inducible factor-1 alpha expression is induced by IL-2 via the PI3K/mTOR pathway in hypoxic NK cells and supports effector functions in NKL cells and ex vivo expanded NK cells.
    Cluff E; Magdaleno CC; Fernandez E; House T; Swaminathan S; Varadaraj A; Rajasekaran N
    Cancer Immunol Immunother; 2022 Aug; 71(8):1989-2005. PubMed ID: 34999917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
    Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
    JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
    Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
    Front Immunol; 2021; 12():668391. PubMed ID: 34539622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early activation and interferon-γ production of tumor-infiltrating mature CD27 high natural killer cells.
    Hayakawa Y; Sato-Matsushita M; Takeda K; Iwakura Y; Tahara H; Irimura T
    Cancer Sci; 2011 Nov; 102(11):1967-71. PubMed ID: 21781225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor microenvironmental conversion of natural killer cells into myeloid-derived suppressor cells.
    Park YJ; Song B; Kim YS; Kim EK; Lee JM; Lee GE; Kim JO; Kim YJ; Chang WS; Kang CY
    Cancer Res; 2013 Sep; 73(18):5669-81. PubMed ID: 23867469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype and Function of Activated Natural Killer Cells From Patients With Prostate Cancer: Patient-Dependent Responses to Priming and IL-2 Activation.
    Hood SP; Foulds GA; Imrie H; Reeder S; McArdle SEB; Khan M; Pockley AG
    Front Immunol; 2018; 9():3169. PubMed ID: 30761160
    [No Abstract]   [Full Text] [Related]  

  • 10. A hypoxia-induced decrease of either MICA/B or Hsp70 on the membrane of tumor cells mediates immune escape from NK cells.
    Schilling D; Tetzlaff F; Konrad S; Li W; Multhoff G
    Cell Stress Chaperones; 2015 Jan; 20(1):139-47. PubMed ID: 25103413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis.
    Zhang S; Liu W; Hu B; Wang P; Lv X; Chen S; Shao Z
    Front Immunol; 2020; 11():1242. PubMed ID: 32714321
    [No Abstract]   [Full Text] [Related]  

  • 12. The E3 Ubiquitin Ligase FBXO38 Maintains the Antitumor Function of Natural Killer Cells by Sustaining IL15R Signaling.
    Shi Y; Zheng X; Peng H; Xu C; Sun R; Tian Z; Sun H; Wang X
    Cancer Immunol Res; 2024 Oct; 12(10):1438-1451. PubMed ID: 38990095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of Hypoxia Inducible Factor-1α in Primary Human Natural Killer Cells Using Small Interfering RNA Delivery with ExPERT ATx by MaxCyte.
    Velásquez SY; Baslar GE; Schulte J; Fuderer T; Lindner HA; Coulibaly A
    Curr Protoc; 2024 Feb; 4(2):e987. PubMed ID: 38327104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and metabolic targeting of natural killer cells to solid tumors.
    Wang J; Matosevic S
    Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1α induces immune escape of prostate cancer by regulating NCR1/NKp46 signaling through miR-224.
    Chen CH; Li SX; Xiang LX; Mu HQ; Wang SB; Yu KY
    Biochem Biophys Res Commun; 2018 Sep; 503(1):228-234. PubMed ID: 29885835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-Associated Monocytes/Macrophages Impair NK-Cell Function via TGFβ1 in Human Gastric Cancer.
    Peng LS; Zhang JY; Teng YS; Zhao YL; Wang TT; Mao FY; Lv YP; Cheng P; Li WH; Chen N; Duan M; Chen W; Guo G; Zou QM; Zhuang Y
    Cancer Immunol Res; 2017 Mar; 5(3):248-256. PubMed ID: 28148545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of CXCR3 improves anti-myeloma efficacy of adoptively transferred activated natural killer cells.
    Bonanni V; Antonangeli F; Santoni A; Bernardini G
    J Immunother Cancer; 2019 Nov; 7(1):290. PubMed ID: 31699153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer learning between preclinical models and human tumors identifies a conserved NK cell activation signature in anti-CTLA-4 responsive tumors.
    Davis-Marcisak EF; Fitzgerald AA; Kessler MD; Danilova L; Jaffee EM; Zaidi N; Weiner LM; Fertig EJ
    Genome Med; 2021 Aug; 13(1):129. PubMed ID: 34376232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-15 Signaling in HIF-1α Regulation in Natural Killer Cells, Insights Through Mathematical Models.
    Coulibaly A; Bettendorf A; Kostina E; Figueiredo AS; Velásquez SY; Bock HG; Thiel M; Lindner HA; Barbarossa MV
    Front Immunol; 2019; 10():2401. PubMed ID: 31681292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation.
    Noman MZ; Desantis G; Janji B; Hasmim M; Karray S; Dessen P; Bronte V; Chouaib S
    J Exp Med; 2014 May; 211(5):781-90. PubMed ID: 24778419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.